Alyeska Investment Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-238,412	Closed	-$2.81M	–	627
2021 Q4	$2.81M	Sell	238,412 -25,000	-9%	-$307K	0.03%	389
2021 Q3	$3M	Buy	263,412 +13,795	+6%	+$180K	0.04%	420
2021 Q2	$3.48M	Buy	249,617 +25,000	+11%	+$380K	0.04%	414
2021 Q1	$4.16M	Sell	224,617 -93,501	-29%	-$1.91M	0.05%	363
2020 Q4	$5.62M	Sell	318,118 -13,421	-4%	-$236K	0.09%	254
2020 Q3	$5.08M	Buy	331,539 +259,062	+357%	+$4.86M	0.08%	263
2020 Q2	$1.85M	Buy	+72,477	New	+$1.51M	0.03%	362
2020 Q1	–	Sell	-387,427	Closed	-$4.29M	–	433
2019 Q4	$4.29M	Buy	387,427 +24,806	+7%	+$216K	0.06%	235
2019 Q3	$3.09M	Buy	362,621 +150,000	+71%	+$1.66M	0.05%	264
2019 Q2	$2.88M	Buy	212,621 +81,119	+62%	+$1.26M	0.04%	289
2019 Q1	$2.38M	Buy	+131,502	New	+$2.54M	0.03%	271
2018 Q3	–	Sell	-84,313	Closed	-$1.46M	–	464
2018 Q2	$1.46M	Buy	+84,313	New	+$1.53M	0.01%	372